To explore whether DTX can mitigate chemokine MCP-1 release, which plays a role in inducing renal tubule atrophy and interstitial fibrosis, thereby hastening GN progression, we measured the serum MCP-1 levels in rats. The gene discussed is CCL2; the disease is ganglioneuroma.